|About Dr. Ming Wang|
|Harvard & MIT
(MD, magna cum laude);
PhD (laser physics)
- Harvard & MIT (MD, magna cum laude); PhD (laser physics)
- Over 55,000 LASIK and cataract procedures (including on over 4,000 doctors)
- The FIRST center in TN to offer laser cataract surgery
- Introduced bladeless all-laser LASIK to the state
- Implanted the state's first Forever Young lens
- The first surgeon in the US to perform a new Intacs surgery to treat keratoconus
- Helped patients from 40 states and 55 countries
- International referral center for cataract surgery and LASIK complications
- Read Dr. Wang's book: LASIK Vision Correction
Why did you decide to have LASIK? Why did you choose Dr. Wang? How has your life changed since your LASIK procedure? What is your advice for people considering LASIK? - Click to see more
|Home||Print This Page|
Presbyopia-correcting IOLs in Patients with Fuchs Dystrophy: Indications and Contraindications
Wang Vision 3D Cataract and LASIK Center, Nashville, Tennessee
Kevin Jackson, OD, Lance Kugler, MD, Ming Wang, MD, PhD
Early evidence indicates that the spatial precision scale provides a useful way to determine whether a given Fuchs dystrophy patient will be able to succeed in a presbyopia-correcting IOL.
Fuchs dystrophy is a clinically significant corneal condition in patients of cataract age. With the growth of PC-IOLs, deciding whether or not a Fuchs patient is a good candidate for a PC-IOL has become increasingly important. To this end, we created the semi-quantitative “spatial precision scale” as a means to assess Fuchs dystrophy patients’ candidacy for PC-IOL implantation. Early indications are that the spatial precision scale may be useful in determining whether a PC-IOL will provide acceptable quality of vision in Fuchs dystrophy patients. Further studies are needed to confirm these findings and to establish a more robust spatial precision scale for clinical application.
To read full article, click here.
Dr Wang's new texbooks
A 501c(3) charity that has helped patients from over 40 states in the US and 55 countries, with all sight restoration surgeries performed free-of-charge.